Bicycle Therapeutics Stock Investor Sentiment
| BCYC Stock | USD 20.40 0.05 0.25% |
About 56% of Bicycle Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Bicycle Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Bicycle Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Bicycle Therapeutics stock news signals to limit their universe of possible portfolio assets.
Bicycle |
Bicycle Therapeutics Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bicycle Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Bicycle Therapeutics that are available to investors today. That information is available publicly through Bicycle media outlets and privately through word of mouth or via Bicycle internal channels. However, regardless of the origin, that massive amount of Bicycle data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bicycle Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bicycle Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bicycle Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bicycle Therapeutics alpha.
Bicycle Therapeutics Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 | 10/02/2024 |
2 | Disposition of 153 shares by Travis Thompson of Bicycle Therapeutics at 22.26 subject to Rule 16b-3 | 10/03/2024 |
3 | Acquisition by Nicholas Keen of 28000 shares of Bicycle Therapeutics subject to Rule 16b-3 | 10/04/2024 |
4 | Bicycle Therapeutics plc Short Interest Up 12.3 percent in September | 10/16/2024 |
5 | Bicycle Therapeutics plc Announces Positive Human Imaging Data at EANM 2024 Congress and Radiopharmaceutical Strategy | 10/23/2024 |
6 | Bicycle Therapeutics Buy Rating Reiterated at Needham Company LLC | 10/25/2024 |
7 | Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results | 10/31/2024 |
8 | Bicycle Therapeutics Looking Again At An Intriguing Developmental Concern - Seeking Alpha | 11/07/2024 |
9 | Disposition of 154 shares by Travis Thompson of Bicycle Therapeutics at 8.21 subject to Rule 16b-3 | 11/11/2024 |
10 | Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference | 11/12/2024 |
11 | Principal Financial Group Inc. Makes New Investment in Bicycle Therapeutics plc - MarketBeat | 11/19/2024 |
12 | Disposition of 1109 shares by Travis Thompson of Bicycle Therapeutics at 9.82 subject to Rule 16b-3 | 11/20/2024 |
13 | Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update | 11/25/2024 |
Complementary Tools for Bicycle Stock analysis
When running Bicycle Therapeutics' price analysis, check to measure Bicycle Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bicycle Therapeutics is operating at the current time. Most of Bicycle Therapeutics' value examination focuses on studying past and present price action to predict the probability of Bicycle Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bicycle Therapeutics' price. Additionally, you may evaluate how the addition of Bicycle Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |